Natural Product-Based Screening for Lead Compounds Targeting SARS CoV-2 M<sup>pro</sup>
Drugs that cure COVID-19 have been marketed; however, this disease continues to ravage the world without becoming extinct, and thus, drug discoveries are still relevant. Since M<sup>pro</sup> has known advantages as a drug target, such as the conserved nature of the active site and the a...
Saved in:
Main Authors: | Jie Chen (Author), Xiang Zhou (Author), Lifeng Fu (Author), Haiyu Xu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of Polyphenolic Natural Products as SARS-CoV-2 M<sup>pro</sup> Inhibitors for COVID-19
by: Nadine Krüger, et al.
Published: (2023) -
Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease Inhibitors
by: Maria Nuria Peralta-Moreno, et al.
Published: (2023) -
SARS-CoV-2 M<sup>pro</sup> Inhibitors: Achieved Diversity, Developing Resistance and Future Strategies
by: Conrad Fischer, et al.
Published: (2023) -
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 M<sup>pro</sup>, Impairing Variants Replication In Vitro and In Vivo
by: Otávio Augusto Chaves, et al.
Published: (2021) -
Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PL<sup>pro</sup>) Inhibitor
by: Sebastjan Kralj, et al.
Published: (2024)